Drugs for disorders of bone: pharmacological and clinical considerations

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Leukemia·2009

Locally delivered lovastatin nanoparticles enhance fracture healing in rats.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2007

Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Bone·2004

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.

The Journal of clinical investigation·2003

Osteoporosis: pathophysiology and non-pharmacological management.

Best practice & research. Clinical rheumatology·2002

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Drugs·2026

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Drugs·2026

Doravirine/Islatravir: First Approval.

Drugs·2026

Anbenitamab: First Approval.

Drugs·2026

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Drugs·2026

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Drugs·2026

Complementary roles of Smad6 and Smad7 in BMP-15-mediated steroidogenic regulation in granulosa cells.

Biochemical and biophysical research communications·2026

Oral PCSK9 inhibitors: closing the gap between potency and practicality.

Current opinion in lipidology·2026

SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.

Journal of bone metabolism·2026

Benzodiazepines in Epilepsy: A US Perspective on Clinical Use, Pharmacology, Abuse Methods, and Public Health Considerations.

Neurology and therapy·2026

Public funding for paediatric medications in Canada.

Paediatrics & child health·2026

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

The Journal of membrane biology·2026

Related Experiment Videos

Drugs for disorders of bone: pharmacological and clinical considerations

Related Concept Videos

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Locally delivered lovastatin nanoparticles enhance fracture healing in rats.

Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.

Osteoporosis: pathophysiology and non-pharmacological management.

Antibiotic-Refractory Chronic Pouchitis After Ileal Pouch-Anal Anastomosis: Current and Emerging Therapeutic Strategies.

Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Doravirine/Islatravir: First Approval.

Anbenitamab: First Approval.

GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials.

Complementary roles of Smad6 and Smad7 in BMP-15-mediated steroidogenic regulation in granulosa cells.

Oral PCSK9 inhibitors: closing the gap between potency and practicality.

SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.

Benzodiazepines in Epilepsy: A US Perspective on Clinical Use, Pharmacology, Abuse Methods, and Public Health Considerations.

Public funding for paediatric medications in Canada.

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

Related Experiment Videos

Drugs for disorders of bone: pharmacological and clinical considerations

Related Concept Videos

Related Articles